A detailed history of Vise Technologies, Inc. transactions in Merck & Co., Inc. stock. As of the latest transaction made, Vise Technologies, Inc. holds 28,306 shares of MRK stock, worth $2.82 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares
28,306
Previous 33,096 14.47%
Holding current value
$2.82 Million
Previous $4.1 Million 21.55%
% of portfolio
0.42%
Previous 0.73%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$111.15 - $128.97 $532,408 - $617,766
-4,790 Reduced 14.47%
28,306 $3.21 Million
Q2 2024

Aug 01, 2024

BUY
$123.8 - $132.96 $21,912 - $23,533
177 Added 0.54%
33,096 $4.1 Million
Q1 2024

May 15, 2024

SELL
$113.24 - $131.95 $349,458 - $407,197
-3,086 Reduced 8.57%
32,919 $4.34 Million
Q4 2023

Feb 07, 2024

BUY
$100.18 - $109.02 $2.29 Million - $2.49 Million
22,884 Added 174.41%
36,005 $3.93 Million
Q3 2023

Oct 31, 2023

SELL
$102.95 - $114.33 $619,964 - $688,495
-6,022 Reduced 31.46%
13,121 $1.35 Million
Q2 2023

Aug 08, 2023

SELL
$108.61 - $118.38 $224,388 - $244,573
-2,066 Reduced 9.74%
19,143 $2.21 Million
Q1 2023

May 10, 2023

BUY
$102.94 - $114.86 $68,043 - $75,922
661 Added 3.22%
21,209 $2.26 Million
Q4 2022

Feb 09, 2023

BUY
$87.44 - $112.11 $3,410 - $4,372
39 Added 0.19%
20,548 $2.28 Million
Q3 2022

Nov 14, 2022

BUY
$84.53 - $94.96 $299,658 - $336,633
3,545 Added 20.9%
20,509 $1.77 Million
Q2 2022

Aug 15, 2022

BUY
$83.49 - $94.64 $559,549 - $634,277
6,702 Added 65.31%
16,964 $1.55 Million
Q1 2022

Jun 08, 2022

BUY
$73.51 - $82.4 $754,359 - $845,588
10,262 New
10,262 $842,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $252B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Vise Technologies, Inc. Portfolio

Follow Vise Technologies, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vise Technologies, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Vise Technologies, Inc. with notifications on news.